Business Standard

Binnopharm to acquire 2 anti-bacterial brands from Dr Reddy's

During the transition period, Dr Reddy's will continue to supply the product to Binnopharm Group to ensure availability in the market

Dr Reddy's
Premium

Dr Reddy's Laboratories

Press Trust of India New Delhi
Sistema Group company Binnopharm Group will acquire Dr Reddy's Laboratories' anti-bacterial medicines under the Ciprolet and Levolet brands in Russia, Uzbekistan and Belarus, the companies said in a joint statement on Monday.

The Binnopharm Group, which is one of the leading pharmaceutical production companies in Russia, has inked a deal with Dr Reddy's in this regard. The product portfolio includes various dosage forms such as tablets, solution for infusions and eye drops. The companies, however, did not disclose financial details.

“The acquisition of Ciprolet and Levolet is an important step to enhance our position in the antibiotics market, one of the key

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 22 2022 | 1:51 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com